Who owns Capstone Therapeutics Corporat?
- Ticker: CAPS
- CUSIP Number: 14068e208
Tip: Access positions for across all investors
Analyze quarterly positions in Capstone Therapeutics Corporat with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Capstone Therapeutics Corporat stock
Who bought or sold Capstone Therapeutics Corporat this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Geode Capital Management | 62k | $41k | 100% | Mar 2026 |
|
| UBS Group | 61.00 | $40.998100 | -98% | Mar 2026 |
|
| Citigroup | 1.00 | $1.000000 | 100% | Mar 2026 |
|
| Morgan Stanley | 1.00 | $1.000000 | 0% | Mar 2026 |
|
Who sold out of Capstone Therapeutics Corporat?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| DRW Holdings | Dec 2025 | 125k | $91k |
| Tower Research Capital | Sep 2025 | 5.5k | $7.3k |
| KERR FINANCIAL PLANNING Corp | Dec 2025 | 75.00 | $363.997500 |